title: Dopamine receptor-mediated activation of phospholipase C is associated with natriuresis during high salt intake.
abstract: Activation of phospholipase C (PLC) is considered to be one of the cellular signaling events involved in dopamine (DA)-mediated natriuresis. In the present study we have examined the role of renal cortical PLC in contributing to the increase in urinary sodium excretion during high sodium intake and its relationship with intrarenal DA synthesis. Rats were given either 1% NaCl (high sodium intake) or tap water (normal sodium intake) to drink for 24 h, and urine was collected over this time period. PLC activity in the renal cortex from these rats was measured by prelabeling cortical slices with myo-[2-3H]inositol and was expressed as fractional release (FR) of inositol (mono-, bis-, and tris-) phosphates. Acute increase in sodium intake produced 93 +/- 8% increase over control in urinary DA excretion. These changes were accompanied by significant increases (30 +/- 8%) in basal FR of inositol phosphates and 243 +/- 40 and 76 +/- 14% increases in urinary sodium and water excretion, respectively. The elevated basal PLC activity in rats with high sodium intake was significantly reduced in the presence of Sch 23390, a selective DA-1 receptor antagonist. Exogenously added DA (3 mM) also produced significant increases in PLC activity, although the magnitudes of increases were different in rats with high (37 +/- 8%) and normal (66 +/- 9%) sodium intake. However, Sch 23390 alone or carbidopa pretreatment did not affect the basal PLC activity in rats maintained on normal sodium intake.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pharmacology, University of Houston, Texas 77204-5515.
authors.forename: S J
authors.initials: SJ
authors.lastname: Vyas
authors.forename: A L
authors.initials: AL
authors.lastname: Jadhav
authors.forename: J
authors.initials: J
authors.lastname: Eichberg
authors.forename: M F
authors.initials: MF
authors.lastname: Lokhandwala
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D002230:Carbidopa / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology* / Q000652:urine; D004789:Enzyme Activation; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000378:metabolism; D007668:Kidney / Q000201:enzymology / Q000502:physiology*; D007672:Kidney Cortex / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D009318:Natriuresis / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D012016:Reference Values; D012982:Sodium, Dietary / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000378:metabolism*
chemical_list: D001552:Benzazepines; D007295:Inositol Phosphates; D011954:Receptors, Dopamine; D012982:Sodium, Dietary; D010738:Type C Phospholipases; D002230:Carbidopa; D004298:Dopamine